Valley Brook Capital Group Inc. decreased its holdings in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 7.0% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 9,273 shares of the company’s stock after selling 693 shares during the quarter. Procter & Gamble accounts for about 1.2% of Valley Brook Capital Group Inc.’s investment portfolio, making the stock its 25th biggest position. Valley Brook Capital Group Inc.’s holdings in Procter & Gamble were worth $1,606,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently modified their holdings of the business. Acorn Creek Capital LLC raised its position in Procter & Gamble by 2.8% during the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock worth $376,000 after buying an additional 59 shares during the last quarter. Patrick M Sweeney & Associates Inc. lifted its position in Procter & Gamble by 1.1% in the third quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock valued at $963,000 after purchasing an additional 59 shares during the period. Alera Investment Advisors LLC increased its position in Procter & Gamble by 1.2% during the 1st quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock worth $812,000 after purchasing an additional 60 shares during the period. Hudson Value Partners LLC raised its stake in shares of Procter & Gamble by 4.1% during the 2nd quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock worth $250,000 after buying an additional 60 shares in the last quarter. Finally, Traveka Wealth LLC boosted its stake in shares of Procter & Gamble by 1.7% in the third quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock valued at $616,000 after buying an additional 60 shares in the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
PG has been the subject of a number of recent analyst reports. DZ Bank raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price for the company in a report on Thursday, August 29th. StockNews.com downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Wolfe Research raised Procter & Gamble to a “strong-buy” rating in a research note on Friday, August 23rd. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $164.00 price objective on shares of Procter & Gamble in a research note on Monday, October 21st. Nine investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $177.00.
Procter & Gamble Trading Up 0.9 %
Procter & Gamble stock traded up $1.48 during midday trading on Thursday, reaching $162.53. The stock had a trading volume of 535,390 shares, compared to its average volume of 6,622,994. The stock has a market capitalization of $382.76 billion, a PE ratio of 27.76, a price-to-earnings-growth ratio of 3.57 and a beta of 0.42. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The stock’s 50-day simple moving average is $171.29 and its 200 day simple moving average is $168.13. The Procter & Gamble Company has a twelve month low of $142.50 and a twelve month high of $177.94.
Procter & Gamble (NYSE:PG – Get Free Report) last posted its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. During the same quarter in the prior year, the company earned $1.83 EPS. The company’s revenue was down .6% on a year-over-year basis. Analysts expect that The Procter & Gamble Company will post 6.94 EPS for the current year.
Procter & Gamble Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.48%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s dividend payout ratio is presently 69.48%.
Insider Transactions at Procter & Gamble
In other Procter & Gamble news, CEO Jon R. Moeller sold 72,174 shares of the stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $171.01, for a total value of $12,342,475.74. Following the completion of the sale, the chief executive officer now owns 263,158 shares of the company’s stock, valued at $45,002,649.58. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, insider Susan Street Whaley sold 450 shares of the stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total value of $76,149.00. Following the completion of the transaction, the insider now owns 13,072 shares of the company’s stock, valued at approximately $2,212,043.84. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Jon R. Moeller sold 72,174 shares of Procter & Gamble stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $171.01, for a total value of $12,342,475.74. Following the sale, the chief executive officer now owns 263,158 shares in the company, valued at $45,002,649.58. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 385,771 shares of company stock valued at $65,610,975 over the last quarter. Company insiders own 0.18% of the company’s stock.
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Articles
- Five stocks we like better than Procter & Gamble
- 3 Stocks to Consider Buying in October
- Breakout Alert: Qualcomm Just Hit The Rally Button
- 3 Small Caps With Big Return Potential
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Atlassian Is Up +60% in Three Months—What’s Causing the Rally?
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.